Notes Payable (Details Textual) - USD ($) |
1 Months Ended | 2 Months Ended | 12 Months Ended | ||
|---|---|---|---|---|---|
Feb. 29, 2016 |
Mar. 31, 2015 |
Dec. 31, 2014 |
Dec. 31, 2016 |
Dec. 31, 2015 |
|
| Debt [Line Items] | |||||
| Debt Instrument, Unamortized Discount (Premium), Net | $ 324,000 | ||||
| Amortization of Debt Discount (Premium) | $ 0 | $ 324,000 | $ 89,000 | ||
| NSC Note [Member] | |||||
| Debt [Line Items] | |||||
| Class of Warrant or Right, Number of Securities Called by Warrants or Rights | 139,592 | ||||
| Class Of Warrant or Right ,Value Of Warrant On Proceeds On Note Payable, Percentage | 25.00% | ||||
| Class Of warrant Or Right ,Warrant Term | 10 years | ||||
| Repayments of Debt | $ 2,800,000 | 2,792,000 | |||
| Debt Instrument, Unamortized Discount (Premium), Net | 0 | (324,000) | |||
| Amortization of Debt Discount (Premium) | 324,000 | 89,000 | |||
| Interest Expense, Debt | $ 20,000 | 146,000 | |||
| Debt Instrument, Interest Rate, Stated Percentage | 8.00% | ||||
| Long-term Debt, Gross | $ 2,800,000 | $ 0 | $ 2,792,000 | ||
| NSC Note [Member] | Fortress Biotech, Inc [Member] | |||||
| Debt [Line Items] | |||||
| Notes Payable | $ 10,000,000 | ||||
| X | ||||||||||
- Definition This element represent that percentage of warrant value as compared to proceeds from notes payables. No definition available.
|
| X | ||||||||||
- Definition This element represent that period of warrant term. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
| X | ||||||||||
- Definition Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Contractual interest rate for funds borrowed, under the debt agreement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount, after accumulated amortization, of debt discount (premium). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Amount of the cost of borrowed funds accounted for as interest expense for debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Including the current and noncurrent portions, aggregate carrying amount of all types of notes payable, as of the balance sheet date, with initial maturities beyond one year or beyond the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations. No definition available.
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|